Skip to main content

The Asthma and Allergy Foundation of America (AAFA) is sharing this press release from the 2021 American College of Allergy, Asthma & Immunology Annual Meeting to bring you the latest research news. This year's meeting is being held Nov. 4-8 in New Orleans, Louisiana.


[PRESS RELEASE]

Lea la versión en español de este comunicado de prensa.

Possible Allergic Reaction to COVID-19 Vaccine Shouldn't Mean Skipping the Vaccine

Two new studies show it’s possible to be vaccinated despite prior indication of allergic reactions

NEW ORLEANS (November 5, 2021) – Some people in the United States have expressed concern over getting one of the three currently available COVID-19 vaccines due to fear of an allergic reaction to the ingredients. Two new studies being presented at this year’s American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting show most people who think they will have an allergic reaction, or who believe they have had an allergic response to the first vaccine, can safely be fully vaccinated.

The first study looked at the charts of 100 patients who listed polyethylene glycol (PEG) as an allergy. PEG is an ingredient in the mRNA COVID-19 vaccines, and people are often asked if they have a PEG allergy prior to receiving an immunization. “Despite their previous reactions to PEG in oral PEG preparations, all 100 patients tolerated the full vaccine series without allergic symptoms,” says Mitchell Pitlick, MD, ACAAI member and lead author of the study.

Of the 100 patients, 64 received the Pfizer vaccine, 33 received the Moderna vaccine and 3 received the Janssen (J&J) vaccine. “Our cohort consisted primarily of patients who experienced gastrointestinal intolerance with an oral PEG preparation,” said allergist Miguel Park, MD, ACAAI member and co-author of the study. “This is unlikely to represent a true PEG allergy and shouldn’t delay vaccination. It’s important to recognize true vs. non-allergic reactions.”

The second study examined medical records of 25 patients referred to an allergy clinic who had reported Adverse Events Following Immunization (AEFI) to one of the mRNA COVID-19 vaccines. “Of the 25 patients, 23 experienced adverse symptoms following the first dose of the mRNA COVID-19 vaccine,” said allergist Benjamin St. Clair, DO, ACAAI member and lead author of the study. “16 had immediate reactions, 6 of 16 underwent skin testing with no positive results. With directed testing or other assessments, 15 underwent a vaccine challenge with only mild, expected post-vaccine symptoms.”

Only 2 of the 8 remaining patients with adverse symptoms following the first dose were advised by the allergist not to receive the second dose. “This study shows that with appropriate specialty evaluation by an allergist, the majority of patients with AEFI can tolerate the second dose of the mRNA vaccine to complete the series.” says Dr. St. Clair.

Abstract Title: Polyethylene Glycol Allergy Label: Not an Absolute Contraindication to Receiving an mRNA COVID-19 Vaccine
Presenter: Mitchell Pitlick, MD

Abstract Title: mRNA COVID-19 Vaccine Adverse Events Following Immunization: Should You Recommend the Second Dose?
Presenter: Benjamin St. Clair, DO

For more information about allergic reactions to vaccines, or to find an allergist in your area, visit AllergyandAsthmaRelief.org. The ACAAI Virtual Annual Meeting is Nov. 4-8. For more news and research from the ACAAI Scientific Meeting, go to our newsroom - and follow the conversation on Twitter #ACAAI21.

About ACAAI

The ACAAI is a professional medical organization of more than 6,000 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit AllergyandAsthmaRelief.org. Join us on Facebook, Pinterest and Twitter.

The Asthma and Allergy Foundation of America (AAFA) is the largest and oldest nonprofit patient organization dedicated to asthma and allergies. Our online community includes public blogs. To post a comment, you will need to register or sign in.

Add Comment

Comments (5)

Newest · Oldest · Popular
There is not enough research to make such a claim. Yours is an opinion and
the study guidelines should be indicated to include how many people were in
the study, their medical history, etc. This is not the forum to encourage
people to get this shot.

On Thu, Nov 11, 2021, 12:07 AM Asthma and Allergy Foundation of America <
support@aafa.org> wrote:
I

@Ironmom316 - Makes an interesting point.  Having talked with the 4 doctors monitoring my bone disease, allergies, the doctors & myself decided getting the COVID-19 vaccines & flu in 2021 shot would help prevent me from getting seriously ill.  I read all the truthful medical research documents, saw the results from medical research hospitals, thankful I got the vaccines. 

Whippetartist

@Whippetartist - hope you can find a booster appointment soon!

@Ironmom316 - we are sharing this latest research so people with asthma and allergies can make informed decisions about the COVID-19 vaccine and whether they can safely receive the vaccine.

Kathy P
I thought that your group would be defending the individual's right to
choose what to put inside their own body. Especially those concerned about
allergies.

On Mon, Nov 8, 2021, 11:19 AM Asthma and Allergy Foundation of America <
support@aafa.org> wrote:
I

Yes!  I got the Pifzer COVID-19 vaccines in March 2021, I had no problem reaction, no side effects.  Now, I'm searching my area to get the COVID-19 booster vaccine.  More than my allergies, allergic asthma, I have Paget's Disease of Bone.  When I go out in public, I must wear a mask & gloves to protect my health. 

Whippetartist
×
×
×
×
Link copied to your clipboard.
×